|
1
|
Jemal A, Siegel R, Ward E, Murray T, Xu J
and Thun MJ: Cancer statistics, 2007. CA Cancer J Clin. 57:43–66.
2007. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Siegel R, Ma J, Zou Z and Jemal A: Cancer
statistics, 2014. CA Cancer J Clin. 64:9–29. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Wang L, Xiong Y, Sun Y, Fang Z, Li L, Ji H
and Shi T: HLungDB: An integrated database of human lung cancer
research. Nucleic Acids Res. 38(Database): D665–D669. 2010.
View Article : Google Scholar :
|
|
4
|
Hecht SS: Tobacco smoke carcinogens and
lung cancer. J Natl Cancer Inst. 91:1194–1210. 1999. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Saintigny P and Burger JA: Recent advances
in non-small cell lung cancer biology and clinical management.
Discov Med. 13:287–297. 2012.PubMed/NCBI
|
|
6
|
Spiller MA: The chemical components of
coffee. Prog Clin Biol Res. 158:91–147. 1984.PubMed/NCBI
|
|
7
|
Lee KA, Chae JI and Shim JH: Natural
diterpenes from coffee, cafestol and kahweol induce apoptosis
through regulation of specificity protein 1 expression in human
malignant pleural mesothelioma. J Biomed Sci. 19:602012. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Cárdenas C, Quesada AR and Medina MA:
Insights on the antitumor effects of kahweol on human breast
cancer: Decreased survival and increased production of reactive
oxygen species and cytotoxicity. Biochem Biophys Res Commun.
447:452–458. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Chae JI, Jeon YJ and Shim JH:
Anti-proliferative properties of kahweol in oral squamous cancer
through the regulation specificity protein 1. Phytother Res.
28:1879–1886. 2014. View
Article : Google Scholar : PubMed/NCBI
|
|
10
|
Cárdenas C, Quesada AR and Medina MA:
Anti-angiogenic and anti-inflammatory properties of kahweol, a
coffee diterpene. PLoS One. 6:e234072011. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Huber WW, Prustomersky S, Delbanco E, Uhl
M, Scharf G, Turesky RJ, Thier R and Schulte-Hermann R: Enhancement
of the chemoprotective enzymes glucuronosyl transferase and
glutathione transferase in specific organs of the rat by the coffee
components kahweol and cafestol. Arch Toxicol. 76:209–217. 2002.
View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Kim JY, Jung KS and Jeong HG: Suppressive
effects of the kahweol and cafestol on cyclooxygenase-2 expression
in macrophages. FEBS Lett. 569:321–326. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Kim JY, Jung KS, Lee KJ, Na HK, Chun HK,
Kho YH and Jeong HG: The coffee diterpene kahweol suppress the
inducible nitric oxide synthase expression in macrophages. Cancer
Lett. 213:147–154. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Tao KS, Wang W, Wang L, Cao DY, Li YQ, Wu
SX and Dou KF: The multifaceted mechanisms for coffee’s
anti-tumorigenic effect on liver. Med Hypotheses. 71:730–736. 2008.
View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Kusumawidjaja G, Kayed H, Giese N, Bauer
A, Erkan M, Giese T, Hoheise JD, Friess H and Kleeff J: Basic
transcription factor 3 (BTF3) regulates transcription of
tumor-associated genes in pancreatic cancer cells. Cancer Biol
Ther. 6:367–376. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Deng JM and Behringer RR: An insertional
mutation in the BTF3 transcription factor gene leads to an early
postimplantation lethality in mice. Transgenic Res. 4:264–269.
1995. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Brockstedt E, Otto A, Rickers A, Bommert K
and Wittmann-Liebold B: Preparative high-resolution two-dimensional
electrophoresis enables the identification of RNA polymerase B
transcription factor 3 as an apoptosis-associated protein in the
human BL60-2 Burkitt lymphoma cell line. J Protein Chem.
18:225–231. 1999. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Dunican DS, McWilliam P, Tighe O,
Parle-McDermott A and Croke DT: Gene expression differences between
the microsatellite instability (MIN) and chromosomal instability
(CIN) phenotypes in colorectal cancer revealed by high-density cDNA
array hybridization. Oncogene. 21:3253–3257. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Odreman F, Vindigni M, Gonzales ML,
Niccolini B, Candiano G, Zanotti B, Skrap M, Pizzolitto S, Stanta G
and Vindigni A: Proteomic studies on low- and high-grade human
brain astrocytomas. J Proteome Res. 4:698–708. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Roy L, Laboissière S, Abdou E, Thibault G,
Hamel N, Taheri M, Boismenu D, Lanoix J, Kearney RE and Paiement J:
Proteomic analysis of the transitional endoplasmic reticulum in
hepatocellular carcinoma: An organelle perspective on cancer.
Biochim Biophys Acta. 1804:1869–1881. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Saraste A and Pulkki K: Morphologic and
biochemical hallmarks of apoptosis. Cardiovasc Res. 45:528–537.
2000. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Bloss TA, Witze ES and Rothman JH:
Suppression of CED-3-independent apoptosis by mitochondrial betaNAC
in Caenorhabditis elegans. Nature. 424:1066–1071. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Thiede B, Dimmler C, Siejak F and Rudel T:
Predominant identification of RNA-binding proteins in Fas-induced
apoptosis by proteome analysis. J Biol Chem. 276:26044–26050. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Pearson G, Robinson F, Beers Gibson T, Xu
BE, Karandikar M, Berman K and Cobb MH: Mitogen-activated protein
(MAP) kinase pathways: Regulation and physiological functions.
Endocr Rev. 22:153–183. 2001.PubMed/NCBI
|
|
25
|
Persons DL, Yazlovitskaya EM and Pelling
JC: Effect of extracellular signal-regulated kinase on p53
accumulation in response to cisplatin. J Biol Chem.
275:35778–35785. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Kris-Etherton PM, Hecker KD, Bonanome A,
Coval SM, Binkoski AE, Hilpert KF, Griel AE and Etherton TD:
Bioactive compounds in foods: Their role in the prevention of
cardiovascular disease and cancer. Am J Med. 113(Suppl 9B):
S71–S88. 2002. View Article : Google Scholar
|
|
27
|
Kim HG, Hwang YP and Jeong HG: Kahweol
blocks STAT3 phosphorylation and induces apoptosis in human lung
adenocarcinoma A549 cells. Toxicol Lett. 187:28–34. 2009.
View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Oh JH, Lee JT, Yang ES, Chang JS, Lee DS,
Kim SH, Choi YH, Park JW and Kwon TK: The coffee diterpene kahweol
induces apoptosis in human leukemia U937 cells through
down-regulation of Akt phosphorylation and activation of JNK.
Apoptosis. 14:1378–1386. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Weusten-Van der Wouw MP, Katan MB, Viani
R, Huggett AC, Liardon R, Liardon R, Lund-Larsen PG, Thelle DS,
Ahola I, Aro A, et al: Identity of the cholesterol-raising factor
from boiled coffee and its effects on liver function enzymes. J
Lipid Res. 35:721–733. 1994.PubMed/NCBI
|
|
30
|
Ratnayake WM, Pelletier G, Hollywood R,
Malcolm S and Stavric B: Investigation of the effect of coffee
lipids on serum cholesterol in hamsters. Food Chem Toxicol.
33:195–201. 1995. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Schilter B, Perrin I, Cavin C and Huggett
AC: Placental glutathione S-transferase (GST-P) induction as a
potential mechanism for the anti-carcinogenic effect of the
coffeespecific components cafestol and kahweol. Carcinogenesis.
17:2377–2384. 1996. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Hammons GJ, Fletcher JV, Stepps KR, Smith
EA, Balentine DA, Harbowy ME and Kadlubar FF: Effects of
chemoprotective agents on the metabolic activation of the
carcinogenic arylamines PhIP and 4-aminobiphenyl in human and rat
liver microsomes. Nutr Cancer. 33:46–52. 1999. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Miller EG, Formby WA, Rivera-Hidalgo F and
Wright JM: Inhibition of hamster buccal pouch carcinogenesis by
green coffee beans. Oral Surg Oral Med Oral Pathol. 65:745–749.
1988. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Cavallini B, Huet J, Plassat JL, Sentenac
A, Egly JM and Chambon P: A yeast activity can substitute for the
HeLa cell TATA box factor. Nature. 334:77–80. 1988. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Zheng XM, Black D, Chambon P and Egly JM:
Sequencing and expression of complementary DNA for the general
transcription factor BTF3. Nature. 344:556–559. 1990. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Kastan MB and Lim DS: The many substrates
and functions of ATM. Nat Rev Mol Cell Biol. 1:179–186. 2000.
View Article : Google Scholar
|
|
37
|
Powers SK, Kavazis AN and McClung JM:
Oxidative stress and disuse muscle atrophy. J Appl Physiol.
102:2389–2397. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Wada T and Penninger JM: Mitogen-activated
protein kinases in apoptosis regulation. Oncogene. 23:2838–2849.
2004. View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Tibbles LA and Woodgett JR: The
stress-activated protein kinase pathways. Cell Mol Life Sci.
55:1230–1254. 1999. View Article : Google Scholar : PubMed/NCBI
|
|
40
|
Zhang W and Liu HT: MAPK signal pathways
in the regulation of cell proliferation in mammalian cells. Cell
Res. 12:9–18. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
41
|
Ahn MY, Ahn JW, Kim HS, Lee J and Yoon JH:
Apicidin inhibits cell growth by downregulating IGF-1R in salivary
mucoepidermoid carcinoma cells. Oncol Rep. 33:1899–1907.
2015.PubMed/NCBI
|
|
42
|
Hyun JH, Kim SC, Kang JI, Kim MK, Boo HJ,
Kwon JM, Koh YS, Hyun JW, Park DB, Yoo ES, et al: Apoptosis
inducing activity of fucoidan in HCT-15 colon carcinoma cells. Biol
Pharm Bull. 32:1760–1764. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
43
|
Zheng Q, Liu Y, Liu W, Ma F, Zhou Y, Chen
M, Chang J, Wang Y, Yang G and He G: Cucurbitacin B inhibits growth
and induces apoptosis through the JAK2/STAT3 and MAPK pathways in
SH-SY5Y human neuroblastoma cells. Mol Med Rep. 10:89–94.
2014.PubMed/NCBI
|
|
44
|
Sheng Z, Knowlton K, Chen J, Hoshijima M,
Brown JH and Chien KR: Cardiotrophin 1 (CT-1) inhibition of cardiac
myocyte apoptosis via a mitogen-activated protein kinase-dependent
pathway. Divergence from downstream CT-1 signals for myocardial
cell hypertrophy. J Biol Chem. 272:5783–5791. 1997. View Article : Google Scholar : PubMed/NCBI
|
|
45
|
Schafer KA: The cell cycle: A review. Vet
Pathol. 35:461–478. 1998. View Article : Google Scholar : PubMed/NCBI
|
|
46
|
Pines J: Cyclins and cyclin-dependent
kinases: Theme and variations. Adv Cancer Res. 66:181–212. 1995.
View Article : Google Scholar : PubMed/NCBI
|
|
47
|
Deng C, Zhang P, Harper JW, Elledge SJ and
Leder P: Mice lacking p21CIP1/WAF1 undergo normal development, but
are defective in G1 checkpoint control. Cell. 82:675–684. 1995.
View Article : Google Scholar : PubMed/NCBI
|
|
48
|
Pan ZQ, Reardon JT, Li L, Flores-Rozas H,
Legerski R, Sancar A and Hurwitz J: Inhibition of nucleotide
excision repair by the cyclin-dependent kinase inhibitor p21. J
Biol Chem. 270:22008–22016. 1995. View Article : Google Scholar : PubMed/NCBI
|
|
49
|
Yasutis KM and Kozminski KG: Cell cycle
checkpoint regulators reach a zillion. Cell Cycle. 12:1501–1509.
2013. View Article : Google Scholar : PubMed/NCBI
|
|
50
|
Khan S, Ferguson Bennit H, Asuncion
Valenzuela MM, Turay D, Diaz Osterman CJ, Moyron RB, Esebanmen GE,
Ashok A and Wall NR: Localization and upregulation of survivin in
cancer health disparities: A clinical perspective. Biologics.
9:57–67. 2015.PubMed/NCBI
|
